Press releases 2024

 


ADDvise receives order worth USD 1.4 million

Regulatory press release

Axelerist, an ADDvise Group company, has received an order from Vertex Pharmaceuticals, a global biotechnology company, for the sale and rental of medical and laboratory equipment. The order value amounts to USD 1.4 million. Delivery will take place over a four-year period starting in Q3 2024. For further information, please contact: Rikard Akhtarzand, CEO +46…

Read more

ADDvise Group plans to change listing venue to Nasdaq Stockholm main market

Regulatory press release

ADDvise Group AB (publ) ("ADDvise Group") has initiated the process of listing the company's A and B shares on Nasdaq Stockholm. The change of listing venue is expected to be completed in the first quarter of 2025. As part of the continued development of ADDvise Group, the company has for some time reviewed the possibility…

Read more

Report from the annual general meeting of ADDvise Group AB (publ) on 3 May 2024

Regulatory press release

ADDvise Group AB (publ), reg. no. 556363-2115, has held its annual general meeting on 3 May 2024 at 10 a.m. CEST at the company’s premises at Grev Turegatan 30 in Stockholm. At the meeting it was resolved on, among other things, re-election of Staffan Torstensson, Fredrik Celsing, Johanne Brændgaard and Anna Ljung as board members,…

Read more

Oliver Humlen is appointed new CEO of ADDvise Group, succeeding Rikard Akhtarzand who will transition to a board and active shareholder role

Regulatory press release

ADDvise Group has appointed Oliver Humlen as new CEO, effective September 1, 2024. He will succeed Rikard Akhtarzand who will take up the position as CEO of Your.Online, a European serial acquirer platform backed by Strikwerda Investments. Rikard will remain a significant and long-term shareholder in ADDvise Group and is nominated to the Board of…

Read more

ADDvise receives order worth USD 11.3 million

Regulatory press release

MRC Systems, an ADDvise Group company, has received an order from leading Omani biopharmaceutical company Opal Bio Pharma. The initial order value amounts to USD 11.3 million with an extension option amounting to an additional USD 6.8 million. The order involves the design, supply, installation and validation of cleanroom panelling, HVAC and accessories for a…

Read more

ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm

Regulatory press release

On 4 April 2024, ADDvise Group AB (publ) (“ADDvise”) issued senior secured bonds in an amount of USD 60 million, under a total framework of USD 200 million (the “Bonds”). Pursuant to the terms and conditions for the Bonds, ADDvise has undertaken to apply for admission to trading of the Bonds on the corporate bond…

Read more

Interim report 2024, January 1 – March 31

Regulatory press release

The first quarter saw a continued favourable revenue development. The Lab segment delivered strong organic growth whereas our pharmaceuticals business affected the Group negatively. The changing product mix resulted in lower margins. Work continued to optimise the capital structure and profit for the period improved.

Read more

ADDvise receives allocation decision worth EUR 1.25 million

Regulatory press release

ADDvise Group AB (publ)’s subsidiary Sonar Oy has received an allocation decision from the Kanta-Häme region worth EUR 1.25 million. The allocation decision pertains to the delivery of x-ray equipment to three hospitals in the region during 2024 and early 2025. The allocation decision is subject to a customary appeals period. For further information, please…

Read more

Invitation to presentation of interim report January 1 – March 31, 2024

Non-regulatory press release

ADDvise Group’s interim report for the period January 1 – March 31, 2024 will be published on April 18, 2024 at 07:45 (CEST). Investors, analysts, and other stakeholders are invited to a webcast and conference call at 14:00 (CEST) / 08:00 AM (EST) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will…

Read more

ADDvise Group publishes annual report and sustainability report for 2023

Regulatory press release

Today, ADDvise Group AB (publ) is publishing the annual report and the sustainability report for 2023. Both reports are available on ADDvise’s website: www.addvisegroup.com. The annual report and the sustainability report are published in Swedish and English. The Swedish versions represent the originals. For further information, please contact: Rikard Akhtarzand, CEO +46 (0)76-525 90 71…

Read more

Notice to the annual general meeting of ADDvise Group AB (publ)

Regulatory press release

ADDvise Group AB (publ), reg. no. 556363–2115, hereby convenes the annual general meeting on 3 May 2024 at 10:00 CEST at Grev Turegatan 30 in Stockholm. Entrance and registration start at 09.30 CEST. NOTIFICATION Shareholders wishing to attend the annual general meeting must: i)          be registered in the share register kept by Euroclear Sweden AB on the…

Read more

ADDvise issues new USD senior secured bonds and partially repurchases outstanding SEK senior secured bonds

Regulatory press release

ADDvise Group AB (publ) (the “Company”) announces today that it has successfully placed senior secured bonds in an amount of USD 60 million under a framework of USD 200 million with a tenor of 3 years (the “New Bonds” or the “Bond Issue”). The New Bonds will carry floating rate interest of SOFR plus 4.25…

Read more

ADDvise considers issuance of new USD senior secured bonds and partial buy-back offer in outstanding SEK senior secured bonds

Regulatory press release

ADDvise Group AB (publ) (“ADDvise” or the “Company”) has mandated Pareto Securities AB and Skandinaviska Enskilda Banken AB (publ) to arrange a series of credit investor meetings commencing on 18 March 2024. To better align the Company’s long-term funding with its operational currency exposure, the Company considers, subject to inter alia market conditions, the issuance…

Read more

ADDvise Group completes a directed new share issue of B shares of approximately SEK 100 million

Regulatory press release

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS, RUSSIA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.…

Read more

ADDvise Group explores the conditions for carrying out a directed new share issue of B shares of approximately SEK 100 million

Regulatory press release

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS, RUSSIA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.…

Read more

The nomination committee’s proposal for board of directors of ADDvise Group AB (publ)

Regulatory press release

To the annual general meeting (AGM) of ADDvise Group AB (publ) on 3 May 2024, the nomination committee has decided to propose re-election of Fredrik Celsing, Staffan Torstensson, Johanne Brændgaard and Anna Ljung as members of the board of directors. In addition, the nomination committee proposes election of Thomas Eklund. Erland Pontusson has declined re-election.…

Read more

Year-end report 2023, January 1-December 31

Regulatory press release

ADDvise delivers its strongest quarter to date and surpasses financial targets for 2023. Net sales increased by 24% and EBITDA amounted to a record SEK 126 million, corresponding to an EBITDA margin of 32%.

Read more

Invitation to presentation of year-end report January 1 – December 31, 2023

Non-regulatory press release

ADDvise Group’s year-end report for the period January 1 – December 31, 2023 will be published on February 22, 2024 at 07:45 (CET). Investors, analysts and other stakeholders are invited to a webcast and conference call at 14:00 (CET) / 08:00 AM (ET) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will…

Read more

ADDvise receives order worth EUR 2.1 million

Regulatory press release

ADDvise Group’s subsidiary Labplan has received an order from the pharmaceutical company Eli Lilly. The order is worth approximately EUR 2.1 million and involves advanced laboratory instruments for quality control purposes. The instruments will be used in a new manufacturing facility for biologic pharmaceuticals in Limerick, Ireland. Delivery of the order is scheduled to the…

Read more

ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm

Regulatory press release

On 20 November 2023, ADDvise Group successfully issued senior secured bonds in an amount of SEK 450 million, under a total framework of SEK 2,000 million. Following the bond issue, in total SEK 1,450 million is outstanding under the framework. Pursuant to the terms and conditions for the bonds, ADDvise has undertaken to apply for…

Read more

ADDvise receives order worth USD 2.5 million

Regulatory press release

ADDvise Group’s subsidiary MRC Systems has received an order from SaudiVax. The company is a biotechnology company specialized in the development and production of vaccines and biopharmaceuticals. The order is worth approximately USD 2.5 million and involves design, installation, and commissioning of a cleanroom and associated accessories. The facility is located in the Kingdom of…

Read more